产品图片
货号/SKU
NR-52153
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-52153??Acinetobacter baumannii, MRSN 1171(Bacteria)|Acinetobacter baumannii|MRSN 1171|-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 1171, NR-52153. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
This item is currently in our production queue. Please allow ample time for distribution lots to be made available.
Acinetobacter baumannii (A. baumannii), strain MRSN 1171 was isolated in 2006 from a human respiratory sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 1171 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52153 was deposited as multi-locus sequence type (MLST) ST 2, sensitive to amikacin, colistin, imipenem and meropenem, intermediately resistant to tobramycin and resistant to ampicillin/sulbactam, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, levofloxacin, tetracycline and trimethoprim/sulfamethoxazole. Strain MRSN 1171 is reported to have five aminoglycoside transferase genes [aac(3)-Ia, aadA1, aph(3’’)-Ib, aph(3’)-Ia and aph(6)-Id; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaOXA-66 and blaTEM-1D; conferring resistance to beta-lactams), a sulfonamide resistance gene (sul1; conferring resistance to sulfonamides) and a tetracycline resistance gene [tet(B); conferring resistance to tetracycline]. The complete genome of A. baumannii, strain MRSN 1171 is available (GenBank: VHHG00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
This item is currently in our production queue. Please allow ample time for distribution lots to be made available.
Acinetobacter baumannii (A. baumannii), strain MRSN 1171 was isolated in 2006 from a human respiratory sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 1171 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52153 was deposited as multi-locus sequence type (MLST) ST 2, sensitive to amikacin, colistin, imipenem and meropenem, intermediately resistant to tobramycin and resistant to ampicillin/sulbactam, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, levofloxacin, tetracycline and trimethoprim/sulfamethoxazole. Strain MRSN 1171 is reported to have five aminoglycoside transferase genes [aac(3)-Ia, aadA1, aph(3’’)-Ib, aph(3’)-Ia and aph(6)-Id; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaOXA-66 and blaTEM-1D; conferring resistance to beta-lactams), a sulfonamide resistance gene (sul1; conferring resistance to sulfonamides) and a tetracycline resistance gene [tet(B); conferring resistance to tetracycline]. The complete genome of A. baumannii, strain MRSN 1171 is available (GenBank: VHHG00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送至NIAID进行批准.
此项目目前处于我们的生产队列中.请允许充足的时间进行分销批次.
肺杆菌（A.Baumannii）（A.Baumannii），菌株MRSN 1171于2006年从美国的人类呼吸样本中分离，作为全球监测计划的一部分.
a. Baumannii ，菌株MRSN 1171作为MRSN 鲍曼杆菌的一部分沉积，从BEI资源作为NR-52248获得的多样性面板. NR-52153沉积为多基因座序列类型（MLST）ST 2，对Amikacin，Colistin，Imipenem和Meropenem敏感，中间抗蛋白霉素和抗氨苄青霉素/苏术酰胺，头孢噻肟，头孢唑胺，头孢曲松，Ciprofloxacin，庆大霉素，左氧氟沙星，四环素和三甲基氯离子/磺胺甲恶唑.菌株MRSN 1171是
据报道，具有五种氨基糖苷类转移酶[ AAC （3）-ia， AAD A1， APH （3'） - IB， APH （3'） - IA和 APH （6）-ID;赋予各种氨基糖苷的耐药性，三种β-内酰胺酶基因（ BLA ADC-25 ， BLA Oxa-66 和 BLA TEM-1d ;赋予β-内酰胺的耐药性，磺酰胺含量抗性基因（ sul 1;
赋予磺胺酰胺的耐药性）和四环素抗性基因[ TET （B）;赋予四环素的抵抗力. a的完整基因组. Baumannii ，应变MRSN 1171可用（Genbank：）.
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养，补充有10％甘油.
patric （Pathosystems资源集成中心）提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2024-01-21
2021-10-31
2019-05-08
2022-04-01
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2022-06-17
2021-12-21
2024-01-21
2024-01-21
2023-11-12
2024-05-19